Loren Bonner

From 2001 to 2020, the overall use of psychotropic medications increased from 5% to 8% for individuals aged 6 years to 34 years, according to a study published in the

If Nicki Hilliard, PharmD, could dole out one piece of advice on gaining reimbursement for pharmacists’ services, it would be to start with patient care, not provider status.

Loren Bonner

As GLP-1 receptor agonists redefine diabetes, obesity, and patient care, attention is turning to how these widely prescribed medications may affect patients beyond blood glucose control and weight loss.

Kaitlyn Valentino, PharmD

Recent research suggests that positioning a pharmacy technician into the vaccinator role positively impacts pharmacists, patient care, and professional motivations.

Jen Hand

As the United States of America celebrates its 250th birthday on July 4, 2026, few professions reflect the nation’s spirit as clearly as pharmacy. Both America and pharmacy share a self-evident optimism, resilience, and drive for innovation.

Brittany Botescu, PharmD

Creative pharmacists often invent system improvements that enhance pharmacy services at their practice site that can be commercialized for use by other practice sites.

David B. Brushwood, BSPharm, JD

Updates from FDA

APhA Staff

The National Sleep Foundation recommends 7 to 9 hours of sleep nightly for adults ages 18 to 64 years.

Lauren Howell, PharmD

Modern wearable fitness trackers can measure biological age via modifiable health metrics such as resting heart rate and activity levels.

Mickie Cathers

Triptans remain a mainstay for acute migraine treatment, but recent data suggest clinicians may need to more closely evaluate patients’ vascular risk before initiating therapy.

Patricia Weiser, PharmD

For years, cholesterol management has largely followed a single script: assess a patient’s risk, start a statin if indicated, and adjust as needed.

Sonya Collins

The combination medication nirmatrelvir–ritonavir has been shown to reduce progression to severe illness from COVID-19 in unvaccinated high-risk patients, but its effectiveness in patients who have been vaccinated, infected naturally, or both is unclear.

APhA Staff

Hospital-acquired UTIs cost hospitals in the United States more than $3.7 billion annually, yet the strategies guiding prevention have been based almost entirely on one target: the indwelling urinary catheter.

Aiya Almogaber, PharmD

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, remains a common and potentially serious cardiovascular condition that requires prompt anticoagulation to prevent recurrence and death.

Corey Diamond, PharmD

For patients with breast cancer receiving myelosuppressive chemotherapy, pegfilgrastim has become a standard tool for preventing febrile neutropenia, but the bone pain it triggers has remained a stubborn, undertreated problem.

Aiya Almogaber, PharmD

Every 5 years, the offer new and updated recommendations to help clinicians, first responders, and lay rescuers work together to improve survival rates and neurological outcomes for adults, children, and infants experiencing cardiac arrest.

Elizabeth Briand

A pharmacist-led outreach program targeting patients at high risk for hypoglycemia can improve medication safety without worsening glycemic control, according to a recent randomized study published in on February 18, 2026.

Sonya Collins

Anemia management in CKD has evolved significantly with the release of the updated KDIGO guideline, reflecting new evidence and emerging therapies.

Lavinia Salama, PharmD, BCACP, BCGP, BC-ADM, CDCES

APhA Member News

APhA staff

Take the Crossword Challenge